Tag: rituximab biosimilars

8, May, 2026

Monoclonal Antibody Biosimilars: Examples, Clinical Uses, and How They Differ from Generics

Explore the world of monoclonal antibody biosimilars, understanding how they differ from generics, reviewing approved examples like bevacizumab and rituximab biosimilars, and examining their clinical uses, safety profiles, and potential for cost savings in modern healthcare.